These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32684121)

  • 1. Pilot study assessing the use of cabergoline for the treatment of cats with hypersomatotropism and diabetes mellitus.
    Scudder CJ; Hazuchova K; Gostelow R; Church DB; Forcada Y; Fowkes RC; Niessen SJ
    J Feline Med Surg; 2021 Feb; 23(2):131-137. PubMed ID: 32684121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism.
    Miceli DD; García JD; Pompili GA; Rey Amunategui JP; Ferraris S; Pignataro OP; Guitelman M
    J Feline Med Surg; 2022 Dec; 24(12):1238-1244. PubMed ID: 35133181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.
    Gostelow R; Scudder C; Keyte S; Forcada Y; Fowkes RC; Schmid HA; Church DB; Niessen SJ
    J Vet Intern Med; 2017 Mar; 31(2):355-364. PubMed ID: 28145031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats.
    van Bokhorst KL; Galac S; Kooistra HS; Valtolina C; Fracassi F; Rosenberg D; Meij BP
    J Vet Intern Med; 2021 Mar; 35(2):834-842. PubMed ID: 33621385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pasireotide for the Medical Management of Feline Hypersomatotropism.
    Scudder CJ; Gostelow R; Forcada Y; Schmid HA; Church D; Niessen SJ
    J Vet Intern Med; 2015; 29(4):1074-80. PubMed ID: 25945588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of growth hormone and insulin-like growth factor 1 in cats with diabetes mellitus.
    Reusch CE; Kley S; Casella M; Nelson RW; Mol J; Zapf J
    Vet Rec; 2006 Feb; 158(6):195-200. PubMed ID: 16474053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and response to treatment in cats with hypersomatotropism: the owners' point of view.
    Corsini A; Niessen SJ; Miceli DD; Caney S; Zeugswetter FK; Sieber-Ruckstuhl NS; Arenas C; Fleeman LM; Leal RO; Battellino M; Fracassi F
    J Feline Med Surg; 2022 Aug; 24(8):e175-e182. PubMed ID: 35616046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of hypophysectomy for the treatment of hypersomatotropism-induced diabetes mellitus in 68 cats.
    Fenn J; Kenny PJ; Scudder CJ; Hazuchova K; Gostelow R; Fowkes RC; Forcada Y; Church DB; Niessen SJM
    J Vet Intern Med; 2021 Mar; 35(2):823-833. PubMed ID: 33624865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus.
    Linari G; Fleeman L; Gilor C; Giacomelli L; Fracassi F
    J Feline Med Surg; 2022 Feb; 24(2):168-176. PubMed ID: 34009061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus remission in three cats with hypersomatotropism after cabergoline treatment.
    Miceli DD; Vidal PN; Pompili GA; Castillo VA; Soler Arias EA; Niessen SJ
    JFMS Open Rep; 2021; 7(1):20551169211018991. PubMed ID: 34158968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of insulin treatment on circulating insulin-like growth factor I and IGF-binding proteins in cats with diabetes mellitus.
    Strage EM; Sundberg M; Holst BS; Andersson Franko M; Ramström M; Fall T; Lewitt M
    J Vet Intern Med; 2018 Sep; 32(5):1579-1590. PubMed ID: 30112786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hypersomatotropism and hyperthyroidism in cats with diabetes mellitus from referral centers in Buenos Aires (2020-2022).
    Miceli DD; García JD; Rey Amunategui JP; Pompili GA; Rial LA; Más J; Molina EM; Pignataro OP
    J Feline Med Surg; 2023 Feb; 25(2):1098612X221148565. PubMed ID: 36779783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter.
    Niessen SJ; Forcada Y; Mantis P; Lamb CR; Harrington N; Fowkes R; Korbonits M; Smith K; Church DB
    PLoS One; 2015; 10(5):e0127794. PubMed ID: 26023776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum N-Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism.
    Keyte SV; Kenny PJ; Forcada Y; Church DB; Niessen SJ
    J Vet Intern Med; 2016 Jul; 30(4):973-82. PubMed ID: 27425382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomographic signs of acromegaly in 68 diabetic cats with hypersomatotropism.
    Lamb CR; Ciasca TC; Mantis P; Forcada Y; Potter M; Church DB; Niessen SJ
    J Feline Med Surg; 2014 Feb; 16(2):99-108. PubMed ID: 23847300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of a protocol for transitioning porcine lente insulin-treated diabetic cats to human recombinant protamine zinc insulin.
    Gostelow R; Hazuchova K; Scudder C; Forcada Y; Church D; Niessen SJ
    J Feline Med Surg; 2018 Feb; 20(2):114-121. PubMed ID: 29172917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and diagnostic potential of serum ghrelin in feline hypersomatotropism and diabetes mellitus.
    Jensen KB; Forcada Y; Church DB; Niessen SJ
    J Vet Intern Med; 2015 Jan; 29(1):14-20. PubMed ID: 25619512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of insulin-like growth factor-binding protein-3 ternary complex in feline diabetes mellitus.
    Lewitt MS; Hazel SJ; Church DB; Watson AD; Powell SE; Tan K
    J Endocrinol; 2000 Jul; 166(1):21-7. PubMed ID: 10856879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands.
    Schaefer S; Kooistra HS; Riond B; Suchodolski JS; Steiner JM; Prins M; Zini E; Reusch CE
    J Feline Med Surg; 2017 Aug; 19(8):888-896. PubMed ID: 27578200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased insulin-like growth factor 1 concentrations in a retrospective population of non-diabetic cats diagnosed with hypertrophic cardiomyopathy.
    Steele MM; Borgeat K; Payne JR; Coss P; Navarro-Cubas X; Church DB; Niessen SJ; Connolly DJ
    J Feline Med Surg; 2021 Oct; 23(10):952-958. PubMed ID: 33541239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.